Joly H - Search Results

1

Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.

Halfon P, Khiri H, Tran A, Pénaranda G, Courcambeck J, Joly H, Ouzan D. Halfon P, et al. Among authors: joly h. Eur J Gastroenterol Hepatol. 2003 Oct;15(10):1067-71. doi: 10.1097/01.meg.0000085472.12407.49. Eur J Gastroenterol Hepatol. 2003. PMID: 14501613

2

[Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes-Maritimes district].

Ouzan D, Cavailler P, Hofliger P, Mamino C, Joly H, Tran A. Ouzan D, et al. Among authors: joly h. Gastroenterol Clin Biol. 2003 Apr;27(4):376-80. Gastroenterol Clin Biol. 2003. PMID: 12759676 Free article. French.

3

Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patients.

Ouzan D, Khiri H, Pénaranda G, Joly H, Halfon P. Ouzan D, et al. Among authors: joly h. Comp Hepatol. 2005 Dec 21;4:9. doi: 10.1186/1476-5926-4-9. Comp Hepatol. 2005. PMID: 16371151 Free PMC article.

4

Optimized HBsAg titer monitoring improves interferon therapy in patients with chronic hepatitis delta.

Ouzan D, Pénaranda G, Joly H, Halfon P. Ouzan D, et al. Among authors: joly h. J Hepatol. 2013 Jun;58(6):1258-9. doi: 10.1016/j.jhep.2012.12.019. Epub 2013 Jan 11. J Hepatol. 2013. PMID: 23318602 Free article. No abstract available.

5

Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogs.

Ouzan D, Pénaranda G, Joly H, Khiri H, Pironti A, Halfon P. Ouzan D, et al. Among authors: joly h. J Clin Virol. 2013 Dec;58(4):713-7. doi: 10.1016/j.jcv.2013.09.020. Epub 2013 Sep 29. J Clin Virol. 2013. PMID: 24183313 Clinical Trial.

6

Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease.

Ouzan D, Mosnier A, Penaranda G, Daviaud I, Joly H, Muntlak M, Cohen JM. Ouzan D, et al. Among authors: joly h. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e986-e991. doi: 10.1097/MEG.0000000000002340. Eur J Gastroenterol Hepatol. 2021. PMID: 34966134 Free PMC article.

7

Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver disease.

Ouzan D, Penaranda G, Jlaiel M, Joly H, Corneille J. Ouzan D, et al. Among authors: joly h. Sci Rep. 2024 May 28;14(1):12198. doi: 10.1038/s41598-024-62549-3. Sci Rep. 2024. PMID: 38806580 Free PMC article.

8

French validation of the sexual complaints screener (SCS) for patients with multiple sclerosis.

Bresch S, Joly H, Colamarino R, Bentellis I, Tur S, Fakir S, Burte C, Lebrun-Frenay C. Bresch S, et al. Among authors: joly h. Rev Neurol (Paris). 2024 Oct 14:S0035-3787(24)00601-5. doi: 10.1016/j.neurol.2024.09.009. Online ahead of print. Rev Neurol (Paris). 2024. PMID: 39406555 Free article.

9

Alexithymia in radiologically isolated syndrome.

Joly H, Gerbier E, Zerlini M, Fabre R, Landes-Château C, Mondot L, Cohen M, Lebrun-Frenay C. Joly H, et al. Mult Scler Relat Disord. 2024 Nov;91:105905. doi: 10.1016/j.msard.2024.105905. Epub 2024 Sep 23. Mult Scler Relat Disord. 2024. PMID: 39341200 Free article.

10

French consensus procedure for neuropsychological assessment in multiple sclerosis.

Jougleux C, Joly H, Brissard H, Lenne B, François S, Hamelin F, Derache N, Morin J, Reuter F, Colamarino R, Ruet A. Jougleux C, et al. Among authors: joly h. Rev Neurol (Paris). 2024 Jul 12:S0035-3787(24)00558-7. doi: 10.1016/j.neurol.2024.06.005. Online ahead of print. Rev Neurol (Paris). 2024. PMID: 39003098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters